AstraZeneca buys US vaccine company in $1.1bn deal
AstraZeneca is buying its first vaccine company in a $1.1bn deal that will expand the vaccine and immune therapy business it set up during the Covid-19 pandemic. Britain’s biggest drugmaker has agreed to take over the Seattle-based firm Icosavax, which is developing a potential vaccine for two…
#astrazeneca #seattle #icosavax #rsv #vlp #gsk #pfizer #massachusetts #moderna #iskrareic